These results collectively suggest that Ac53FaxNeu5Ac treatment at the dose of 10 mg/kg significantly altered the immune cell component of the tumor microenvironment by increasing the infiltrating T cell population, including T CD8+, and by an increasing trend of NK cells, altogether enhancing the immune response against the tumor. Here, CD8A is linked to neoplasm.